4//SEC Filing
QUINLAN KEVIN W 4
Accession 0001140361-12-014284
CIK 0000898437other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 7:06 PM ET
Size
6.0 KB
Accession
0001140361-12-014284
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-03-01+37,500→ 37,500 totalExercise: $6.99Exp: 2022-03-01→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options represents the closing price of the Company's common stock on June 7, 2011, the date the Board of Directors of the Company granted performance-based stock option awards (the "Performance Grant") and approved the performance measures governing such Performance Grant.
- [F2]The stock options were issued under the Performance Grant on March 1, 2012, the date the Compensation Committee of the Company determined that certain performance measures governing the Performance Grant were achieved.
- [F3]The stock options vest in three equal installments as follows: March 1, 2012, January 1, 2013, and January 1, 2014
Documents
Issuer
ANIKA THERAPEUTICS INC
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001209114
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 7:06 PM ET
- Size
- 6.0 KB